TWI719303B - Use of rosa roxburghii fruit extracts for manufacture of composition for cell rejuvenation - Google Patents

Use of rosa roxburghii fruit extracts for manufacture of composition for cell rejuvenation Download PDF

Info

Publication number
TWI719303B
TWI719303B TW107114734A TW107114734A TWI719303B TW I719303 B TWI719303 B TW I719303B TW 107114734 A TW107114734 A TW 107114734A TW 107114734 A TW107114734 A TW 107114734A TW I719303 B TWI719303 B TW I719303B
Authority
TW
Taiwan
Prior art keywords
prickly pear
cells
extract
cell
item
Prior art date
Application number
TW107114734A
Other languages
Chinese (zh)
Other versions
TW201924706A (en
Inventor
林詠翔
蘇郁虹
Original Assignee
大江生醫股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大江生醫股份有限公司 filed Critical 大江生醫股份有限公司
Priority to CN201810741808.3A priority Critical patent/CN109833358A/en
Priority to US16/100,956 priority patent/US20190160131A1/en
Publication of TW201924706A publication Critical patent/TW201924706A/en
Application granted granted Critical
Publication of TWI719303B publication Critical patent/TWI719303B/en

Links

Images

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention provides use of a Rosa roxburghii fruit extract for manufacture of composition for cell rejuvenation. The Rosa roxburghii fruit extract is prepared by extraction of Rosa roxburghii fruits using water, alcohols, or mixtures of water and alcohols as solvents. This extract can promote DNA repair, reduce cell damage caused by oxidative stress or inflammation, maintain normal functions of genes, proteins, and mitochondria, stimulate the telomerase reaction, and reduce telomere damage due to chemicals and UV exposure, thus facilitating cell rejuvenation.

Description

刺梨萃取物用於製備細胞回春組合物之用途 Use of Prickly Pear extract for preparing cell rejuvenation composition

本發明係關於一種刺梨萃取物的保健用途,特別係關於一種刺梨萃取物用於製備細胞回春組合物之組合物之用途。 The present invention relates to the health-care use of a prickly pear extract, in particular to the use of a prickly pear extract to prepare a cell rejuvenation composition.

隨著人口平均年齡的延長,擁有健康而高品質的老年生活成為大眾關注的焦點之一,關於老化的科學研究也越發受重視。個體老化的原因眾多,在分子及細胞層次,可能的內部機制包括染色體末端的端粒(telomere)縮短、基因突變、蛋白質合成效率不良、粒線體功能下降、細胞形態變異等。此外,細胞周圍環境中由物理或化學因素產生的自由基(如活性氧物質)會損害細胞的染色體去氧核醣核酸(DNA)、蛋白質、及脂質生物膜,而個體為因應此類細胞損傷或微生物入侵而啟動的發炎反應一旦發展為慢性發炎更會加劇細胞損傷,因此加速細胞及個體老化。 With the increase of the average age of the population, having a healthy and high-quality elderly life has become one of the focuses of public attention, and scientific research on aging has also become more and more important. There are many reasons for individual aging. At the molecular and cellular levels, possible internal mechanisms include shortening of telomeres at the end of chromosomes, gene mutations, poor protein synthesis efficiency, decreased mitochondrial function, and cell morphological changes. In addition, free radicals (such as reactive oxygen species) generated by physical or chemical factors in the surrounding environment of cells can damage the chromosomal deoxyribonucleic acid (DNA), proteins, and lipid biofilms of cells, and individuals respond to such cell damage or Once the inflammatory response initiated by microbial invasion develops into chronic inflammation, it will aggravate cell damage, thus accelerating the aging of cells and individuals.

對抗老化的方法包括透過飲食獲取天然抗氧化劑以提升個體清除自由基的能力,以及藉由抗發炎藥抑制體內的慢性發炎。鑒於上述複雜的老化成因,針對單一標的而設計的抗老化方法顯然成效不彰。目前新興的幹細胞療法雖然是極具抗老化潛力,然其尚處於發展階段,且治療費用高昂。因此,開發一種簡單的新穎組合物,以複合方式維持個體或細胞處於年輕狀態,實有其必要。 Anti-aging methods include obtaining natural antioxidants through diet to enhance the individual's ability to scavenge free radicals, and anti-inflammatory drugs to inhibit chronic inflammation in the body. In view of the above-mentioned complex aging causes, the anti-aging method designed for a single target is obviously not effective. Although the emerging stem cell therapy has great anti-aging potential, it is still in the development stage and the treatment cost is high. Therefore, it is necessary to develop a simple and novel composition to maintain an individual or cell in a young state in a complex manner.

緣此,本發明之一目的在提供一種刺梨(Rosa roxburghii fruit)萃取物用於製備細胞回春組合物之用途,其中該刺梨萃取物係以一溶劑萃取一刺梨而獲得。 For this reason, one objective of the present invention is to provide a use of Rosa roxburghii fruit extract for preparing a cell rejuvenation composition, wherein the roxburghii fruit extract is obtained by extracting a roxburghii fruit with a solvent.

在本發明之一實施例中,該溶劑為水、醇類、或醇水混合物,該溶劑與刺梨之液固比為5~20:1~5,且該萃取係在50℃~100℃進行。 In an embodiment of the present invention, the solvent is water, alcohol, or a mixture of alcohol and water, the liquid-to-solid ratio of the solvent to the prickly pear is 5-20:1-5, and the extraction is performed at 50°C-100°C get on.

在本發明之一實施例中,該刺梨萃取物係為一刺梨之水萃取物,其濃度為至少0.5mg/mL。 In an embodiment of the present invention, the prickly pear extract is a water extract of prickly pear, with a concentration of at least 0.5 mg/mL.

在本發明之一實施例中,該刺梨萃取物促進一端粒酶之合成,以及增強端粒酶反轉錄酶(telomerase reverse transcriptase,TERT)、端粒酶核醣核酸組分(telomerase RNA component,TERC)、或其組合之基因表現。 In an embodiment of the present invention, the prickly pear extract promotes the synthesis of telomerase, and enhances telomerase reverse transcriptase (TERT) and telomerase RNA component (TERC). ), or a combination of gene expression.

在本發明之一實施例中,該刺梨萃取物減少染色體端粒因化學藥物或紫外線照射而長度縮短。 In one embodiment of the present invention, the prickly pear extract reduces the length of chromosomal telomeres that are shortened due to chemical drugs or ultraviolet radiation.

在本發明之一實施例中,該刺梨萃取物促進基因修復,以及增強一DNA修復蛋白之基因表現,該DNA修復蛋白係選自於由MPG(N-methylpurine DNA glycosylase,N-甲基嘌呤DNA醣基化酶)、ERCC6(excision repair cross complementing 6,核苷酸剪切修復交叉互補蛋白6)、XRCC5(X-ray repair cross complementing 5,X射線修復交叉互補蛋白5)、及其任意組合所組成的群組。 In an embodiment of the present invention, the prickly pear extract promotes gene repair and enhances the gene expression of a DNA repair protein selected from the group consisting of MPG (N-methylpurine DNA glycosylase, N-methylpurine DNA glycosylase), ERCC6 (excision repair cross complementing 6, nucleotide shear repair cross complementing protein 6), XRCC5 (X-ray repair cross complementing 5, X-ray repair cross complementing protein 5), and any combination thereof The group formed.

在本發明之一實施例中,該刺梨萃取物促進一伴隨蛋白T複合體(chaperonin containing TCP1 complex,CCT)之合成,以及增強該伴隨蛋白T複合體之一蛋白次單元之基因表現,該蛋白次單元係選自於由CCT2、CCT5、CCT6A、CCT7、CCT8、及其任意組合所組成的群組。 In an embodiment of the present invention, the prickly pear extract promotes the synthesis of a chaperonin containing TCP1 complex (CCT) and enhances the gene expression of a protein subunit of the chaperonin T complex. The protein subunit is selected from the group consisting of CCT2, CCT5, CCT6A, CCT7, CCT8, and any combination thereof.

在本發明之一實施例中,該刺梨萃取物提升粒線體活性,以及抑制一聚二磷酸腺苷核糖聚合酶(亦稱聚ADP核糖聚合酶,poly(ADP-ribose)polymerase,PARP)之基因表現,該PARP係選自於由PARP1、PARP3、PARP4、PARP8、PARP11、及其任意組合所組成的群組。 In one embodiment of the present invention, the prickly pear extract enhances mitochondrial activity and inhibits adenosine monophosphate ribose polymerase (also known as poly(ADP-ribose) polymerase, PARP) The gene expression of the PARP line is selected from the group consisting of PARP1, PARP3, PARP4, PARP8, PARP11, and any combination thereof.

本發明基於基因表現分析結果,揭示刺梨萃取物能同時減少氧化壓力(oxidative stress)或發炎造成的細胞損傷以及維持基因、蛋白質、與粒線體的正常運作,並且能刺激端粒酶反應與減少端粒因化學藥物或紫外線照射而受損,因此促進細胞回春。因此,本發明提供刺梨萃取物用於製備細胞回春組合 物之用途,該組合物可為粉末狀、顆粒狀、液狀、膠狀或膏狀,且可製成食品、飲品、藥品、試劑或營養補充劑,藉由口服、皮膚塗抹等方式給予一個體。 The present invention, based on the results of gene expression analysis, reveals that Prickly Pear extract can simultaneously reduce cell damage caused by oxidative stress or inflammation and maintain the normal functioning of genes, proteins, and mitochondria, and can stimulate the telomerase reaction and Reduce the damage of telomeres due to chemical drugs or ultraviolet radiation, thus promoting cell rejuvenation. Therefore, the present invention provides thorn pear extract for preparing cell rejuvenation combination The composition can be in the form of powder, granular, liquid, gel or paste, and can be made into food, drink, medicine, reagent or nutritional supplement, and it can be administered by oral administration, skin application, etc. individual.

以下將配合圖式進一步說明本發明的實施方式,下述所列舉的實施例係用以闡明本發明之發明特點及應用,而非以限定本發明之範圍,任何熟習此技藝者,在不脫離本發明之精神和範圍內,當可做些許更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 The following will further illustrate the embodiments of the present invention in conjunction with the drawings. The following examples are used to illustrate the inventive features and applications of the present invention, rather than to limit the scope of the present invention. Anyone familiar with the art will not depart from Within the spirit and scope of the present invention, some changes and modifications can be made. Therefore, the scope of protection of the present invention shall be subject to those defined by the attached patent scope.

圖1顯示受脂多醣(lipopolysaccharide,LPS)刺激的THP-1細胞在有或無刺梨萃取物處理24小時後相對於控制組細胞的超氧化物歧化酶2(superoxide dismutase 2,SOD2)基因之相對表現量。 Figure 1 shows the comparison of superoxide dismutase 2 (SOD2) genes in THP-1 cells stimulated by lipopolysaccharide (LPS) after 24 hours of treatment with or without prickly pear extract compared to the superoxide dismutase 2 (SOD2) gene of control group cells Relative performance.

圖2顯示受脂多醣(LPS)刺激的THP-1細胞在有或無刺梨萃取物處理6小時後相對於控制組細胞的CC趨化因子配體3(C-C motif chemokine ligand 3,CCL3)基因之相對表現量。 Figure 2 shows the CC motif chemokine ligand 3 (CCL3) gene of THP-1 cells stimulated by lipopolysaccharide (LPS) after 6 hours of treatment with or without prickly pear extract compared to the control group cells The relative performance.

圖3顯示受脂多醣(LPS)刺激的THP-1細胞在有或無刺梨萃取物處理6小時後相對於控制組細胞的介白素-1受體拮抗因子(interleukin-1 receptor antagonist,IL-1RA)與介白素-10(interleukin-10,IL-10)基因之相對表現量。 Figure 3 shows that THP-1 cells stimulated by lipopolysaccharide (LPS) were treated with or without prickly pear extract for 6 hours, compared with control group cells for interleukin-1 receptor antagonist (IL). -1RA) and the relative expression levels of interleukin-10 (IL-10) genes.

圖4顯示受脂多醣(LPS)刺激的THP-1細胞在有或無刺梨萃取物處理6小時後相對於控制組細胞的MPG、ERCC6、及XRCC5基因之相對表現量。 Figure 4 shows the relative expression levels of MPG, ERCC6, and XRCC5 genes in THP-1 cells stimulated by lipopolysaccharide (LPS) after 6 hours of treatment with or without prickly pear extract relative to cells in the control group.

圖5顯示經刺梨萃取物處理6小時或24小時的THP-1細胞相對於控制組細胞的CCT2、CCT5、CCT6A、CCT7、及CCT8基因之相對表現量。 Figure 5 shows the relative expression levels of CCT2, CCT5, CCT6A, CCT7, and CCT8 genes in THP-1 cells treated with Cili extract for 6 hours or 24 hours relative to control group cells.

圖6顯示經刺梨萃取物處理6小時或24小時的THP-1細胞相對於控制組細胞的PARP1、PARP3、PARP4、PARP8、及PARP11基因之相對表現量。 Figure 6 shows the relative expression levels of PARP1, PARP3, PARP4, PARP8, and PARP11 genes in THP-1 cells treated with Cili extract for 6 hours or 24 hours relative to control group cells.

圖7顯示經刺梨萃取物處理6小時之THP-1細胞與控制組細胞的TERT與TERC基因之相對表現量。 Figure 7 shows the relative expression levels of TERT and TERC genes in THP-1 cells and control cells treated with Cili extract for 6 hours.

圖8顯示刺梨水萃取物對化學藥物所致皮膚細胞之端粒縮短的抑制作用。 Fig. 8 shows the inhibitory effect of the water extract of Prickly Pear on the telomere shortening of skin cells caused by chemical drugs.

圖9顯示刺梨水萃取物對紫外線照射所致皮膚細胞之端粒縮短的抑制作用。 Fig. 9 shows the inhibitory effect of the water extract of Prickly Pear on the telomere shortening of skin cells caused by ultraviolet radiation.

本發明提供一種刺梨萃取物用於製備細胞回春組合物之用途。本發明之刺梨萃取物係以一溶劑萃取一刺梨而獲得,其中,該溶劑為水、醇類、或醇水混合物,該溶劑與該刺梨之液固比為5~20:1~5,且該萃取係在50℃~100℃進行。基於基因表現量分析技術,該刺梨萃取物經證實能促進抗氧化相關基因、抗發炎細胞激素基因、DNA修復相關蛋白基因、伴隨蛋白T複合體(CCT)之蛋白次單元基因、及端粒酶反應相關基因之表現,並且抑制發炎反應相關基因及粒線體機能失調關聯基因之表現,以及減少染色體端粒因化學藥物或紫外線照射而長度縮短。 The present invention provides a use of extracts of prickly pear for preparing a cell rejuvenation composition. The prickly pear extract of the present invention is obtained by extracting a prickly pear with a solvent, wherein the solvent is water, alcohol, or a mixture of alcohol and water, and the liquid-solid ratio of the solvent to the prickly pear is 5-20:1~ 5. And the extraction is carried out at 50℃~100℃. Based on gene expression analysis technology, the prickly pear extract has been proven to promote antioxidant-related genes, anti-inflammatory cytokine genes, DNA repair-related protein genes, protein subunit genes of the companion protein T complex (CCT), and telomeres The expression of genes related to enzyme reaction, and inhibit the expression of genes related to inflammation reaction and genes related to mitochondrial dysfunction, and reduce the length of chromosome telomeres due to chemical drugs or ultraviolet radiation.

定義definition

本文中所使用數值為近似值,所有實驗數據皆表示在20%的範圍內,較佳為在10%的範圍內,最佳為在5%的範圍內。 The numerical values used herein are approximate values, and all experimental data are expressed in the range of 20%, preferably in the range of 10%, and most preferably in the range of 5%.

本文中所謂「細胞回春」係指逆轉細胞老化現象發生的過程,其可藉由多種生物指標判斷,例如促進參與細胞DNA修復、端粒酶反應、蛋白質正常作用之基因表現,促進與粒線體活性相關之蛋白質或RNA之基因表現,及促進染色體端粒延長。 The so-called "cell rejuvenation" in this article refers to the process of reversing the occurrence of cell aging. It can be judged by a variety of biological indicators, such as promoting the expression of genes involved in cell DNA repair, telomerase reaction, and the normal function of proteins, and promoting interaction with mitochondria. Gene expression of protein or RNA related to activity, and promotes chromosome telomere extension.

材料與方法Materials and Methods 細胞培養Cell culture

以下實施例使用購自美國典型培養物保存中心(American Type Culture Collection,ATCC)之人類單核細胞株(human monocytic cell line)THP-1(ATCC TIB202)及購自食品工業發展研究所生物資源保存及研究中心(Bioresource Collection and Research Center,BCRC)之人類皮膚纖維母細胞(human skin fibroblast)CCD-966SK(BCRC 60153)。THP-1細胞在37℃、5%二氧化碳的條件下培養於添加10%胎牛血清(fetal bovine serum,FBS)與1%青黴素-鏈黴素之RPMI培養基(RPMI medium 1640;Gibco),以下稱RPMI細胞培養基。CCD-966SK細胞在37℃、5%二氧化碳的條件下培養於添加10% FBS及1%青黴素-鏈黴素之最低基礎培養基(Minimum Essential Medium(MEM);Gibco),以下稱MEM細胞培養基。 The following examples use the human monocytic cell line THP-1 (ATCC TIB202) purchased from the American Type Culture Collection (ATCC) and the biological resource preservation purchased from the Food Industry Development Institute And the research center (Bioresource Collection and Research Center, BCRC) human skin fibroblast (human skin fibroblast) CCD-966SK (BCRC 60153). THP-1 cells were cultured in RPMI medium (RPMI medium 1640; Gibco) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (RPMI medium 1640; Gibco) under the condition of 37°C and 5% carbon dioxide. RPMI cell culture medium. CCD-966SK cells were cultured in a minimum basal medium (Minimum Essential Medium (MEM) (MEM); Gibco) supplemented with 10% FBS and 1% penicillin-streptomycin at 37°C and 5% carbon dioxide, hereinafter referred to as MEM cell culture medium.

基因體晶片分析Genome chip analysis

利用人類基因體晶片(由華聯生物科技股份有限公司製造)測定細胞的基因體表現變化,其步驟簡述如下。依據廠商使用說明,利用RNA萃取套組(RNA Extraction Kit;Geneaid)自THP-1細胞分離出RNA,以其為模板於37℃下以帶有T7啟動子(T7 promoter)序列之胸腺嘧啶去氧寡核苷酸引子(oligo dT primer)進行反轉錄以合成第一股互補去氧核醣核酸(cDNA),再以DNA聚合酶及RNA酶H(RNase H)合成雙股cDNA。經純化後,以該雙股cDNA為模板,在添加氨基烯丙基尿苷三磷酸(amino allyl UTP,aaUTP)的環境利用RNA擴增套組(Amino Allyl MessageAmpTM aRNA Amplification kit;Invitrogen)進行試管內轉錄(in vitro transcription)以合成氨基烯丙基修飾的RNA(簡稱aRNA)。經純化後的aRNA可與如Cy5之氨基反應性螢光染劑(Cy5 NHS ester;AAT Bioquest)結合而生成染劑標記的RNA。藉由透析移除未結合的染劑及純化得經染劑標記的RNA後,將其添加至載有複數特定基因探針的人類基因體晶片,以雜合套組(Hybridization kit;Phalanx)進行雜合反應。該複數特定基因所編碼之蛋白質包含抗氧化相關的SOD2、發炎反應相關的CCL3、抗發炎細胞激素IL-1RA與IL-10、DNA修復相關蛋白如MPG、ERCC6、XRCC5、伴隨蛋白T複合體(CCT)之多種蛋白次單元如CCT2、CCT5、CCT6A、CCT7、及CCT8、以及與粒線體機能失調有關之多種聚ADP核糖聚合酶(PARP),包括PARP1、PARP3、PARP4、PARP8、及PARP11。該基因體晶片於雜合反應後係利用微陣列掃描儀(Agilent microarray scanner)偵測雜合的螢光訊號。初始數據經標準化後以log2對數值表示基因的相對表現量。統計分析係使用Excel軟體中的STDEV函數計算各基因相對表現量的標準差,並以單尾學生T檢驗(TTEST)計算統計上差異。 The human genome chip (manufactured by Hualian Biotechnology Co., Ltd.) is used to determine the changes in cell genome performance. The steps are briefly described as follows. According to the manufacturer’s instructions, RNA extraction kit (RNA Extraction Kit; Geneaid) was used to isolate RNA from THP-1 cells, and use it as a template to deoxygenate thymine with T7 promoter sequence at 37°C. The oligo dT primer is used for reverse transcription to synthesize the first complementary deoxyribonucleic acid (cDNA), and then the double-stranded cDNA is synthesized by DNA polymerase and RNase H (RNase H). After purification, the double-stranded cDNA was used as a template, and an RNA amplification kit (Amino Allyl MessageAmp TM aRNA Amplification kit; Invitrogen) was used for test tubes in an environment where amino allyl uridine triphosphate (amino allyl UTP, aaUTP) was added. In vitro transcription is used to synthesize aminoallyl-modified RNA (abbreviated as aRNA). The purified aRNA can be combined with an amino-reactive fluorescent dye such as Cy5 (Cy5 NHS ester; AAT Bioquest) to generate dye-labeled RNA. After removing the unbound dye and purifying the dye-labeled RNA by dialysis, it is added to the human genome chip loaded with a plurality of specific gene probes, and the hybridization kit (Phalanx) is used for processing. Hybrid reaction. The proteins encoded by the plural specific genes include antioxidant-related SOD2, inflammation-related CCL3, anti-inflammatory cytokines IL-1RA and IL-10, DNA repair-related proteins such as MPG, ERCC6, XRCC5, and associated protein T complex ( The various protein subunits of CCT) such as CCT2, CCT5, CCT6A, CCT7, and CCT8, and a variety of poly ADP ribose polymerases (PARPs) related to mitochondrial dysfunction, including PARP1, PARP3, PARP4, PARP8, and PARP11. The genome chip uses an Agilent microarray scanner to detect the heterozygous fluorescent signal after the hybrid reaction. The initial data were normalized to express the relative expression level of genes with log2 logarithmic value. The statistical analysis department uses the STDEV function in Excel software to calculate the standard deviation of the relative expression of each gene, and uses the one-tailed Student’s T test (TTEST) to calculate the statistical difference.

基因表現量分析Gene expression analysis

基於定量聚合酶鏈鎖反應(quantitative polymerase chain reaction,簡稱qPCR)測定細胞中參與端粒酶反應的端粒酶反轉錄酶(TERT)及端粒酶RNA組分(TERC)的基因表現量,其步驟簡述如下。依據廠商使用說明,利用RNA萃取套組(RNA Extraction Kit;Geneaid)自細胞分離出RNA,於37℃下以反轉錄酶SuperScript® III Reverse Transcriptase(Invitrogen)將2000ng RNA反轉錄為cDNA。其次,利用qPCR套組(KAPA CYBR FAST qPCR Kit(2X);KAPA Biosystems)以及TERT、TERC等目標基因與作為內部對照之甘油醛3-磷酸脫氫酶 (Glyceraldehyde 3-phosphate dehydrogenase,GAPDH)基因之引子對(表1)在PCR反應儀(Step One Plus Real-Time PCR system;Applied Biosystems)對前述cDNA進行qPCR,以取得解鏈曲線(melting curve)。 Based on the quantitative polymerase chain reaction (qPCR), the gene expression level of telomerase reverse transcriptase (TERT) and telomerase RNA component (TERC) involved in the telomerase reaction in the cell is measured. The steps are briefly described below. According to the manufacturer's instructions, RNA was isolated from the cells using RNA Extraction Kit (Geneaid), and 2000ng of RNA was reverse-transcribed into cDNA with SuperScript® III Reverse Transcriptase (Invitrogen) at 37°C. Secondly, use the qPCR kit (KAPA CYBR FAST qPCR Kit (2X); KAPA Biosystems) and target genes such as TERT and TERC and glyceraldehyde 3-phosphate dehydrogenase as an internal control The primer pair of (Glyceraldehyde 3-phosphate dehydrogenase, GAPDH) gene (Table 1) was subjected to qPCR on the aforementioned cDNA in a PCR reaction machine (Step One Plus Real-Time PCR system; Applied Biosystems) to obtain a melting curve.

Figure 107114734-A0101-12-0006-1
Figure 107114734-A0101-12-0006-1

最終,使用2-△△CT方法測定目標基因的相對表現量。該方法以GAPDH基因的循環閾值(CT)作為內部對照之參考基因的循環閾值,按照以下公式計算相對倍數變化:△CT=實驗組或控制組的目標基因的CT-內部對照的CT Finally, the 2- △△CT method was used to determine the relative expression level of the target gene. The method is the threshold cycle (C T) GAPDH gene as an internal control of the reference cycle threshold gene, calculated by the following formula relative fold change: C gene of △ C T = the experimental group or the control group T - internal control C T

△△CT=實驗組的△CT-控制組的△CT △△ C T = test group △ C T - △ C T of the control group

倍數變化=2-△△Ct平均值 Multiple change=2 -△△Ct average value

統計分析係使用Excel軟體中的STDEV函數計算各基因相對表現量的標準差,並以單尾學生T檢驗(TTEST)計算統計上差異。 The statistical analysis department uses the STDEV function in Excel software to calculate the standard deviation of the relative expression of each gene, and uses the one-tailed Student’s T test (TTEST) to calculate the statistical difference.

端粒長度測定Telomere length determination

端粒長度係基於qPCR技術而測定。首先,由細胞萃取得基因體DNA樣品。其次,利用qPCR套組(KAPA CYBR FAST qPCR Kit(2X);KAPA Biosystems)以及端粒與36B4基因(單拷貝數基因)之引子對(表2)在PCR反應儀對該基因體DNA樣品(20ng)進行qPCR,以獲得解鏈曲線。同時,製備端粒(自60pg稀釋10至106倍)與36B4基因(自200pg稀釋10至106倍)的連續稀釋標準品,以下列反應條件進行qPCR以獲得該二者的標準曲線(Ct/kb):10分鐘變性階段(95℃),其後為40個循環之15秒變性階段(95℃)與1分鐘黏合階段。作為標準品之端粒係具有14重複之TTAGGG之寡核苷酸(SEQ ID NO:7);作為標準品之36B4基因具有SEQ ID NO:8之核苷酸序列。最終,由前述標準曲線及基因體DNA樣品之端粒與36B4基因的循環閾值計算基因體DNA樣品中端粒的平均長度。 Telomere length is determined based on qPCR technology. First, a genomic DNA sample is extracted from the cells. Secondly, using the qPCR kit (KAPA CYBR FAST qPCR Kit (2X); KAPA Biosystems) and the primer pair of telomere and 36B4 gene (single copy number gene) (Table 2), the genomic DNA sample (20ng ) Perform qPCR to obtain melting curve. Meanwhile, telomere prepared (diluted 10 to 106-fold from 60pg) and 36B4 gene (from 200pg diluted 10 to 106-fold) of serially diluted standards, the following reaction conditions to obtain a standard curve of the qPCR both (Ct /kb): 10-minute denaturation stage (95°C), followed by 40 cycles of 15-second denaturation stage (95°C) and 1-minute bonding stage. The telomere as the standard product is an oligonucleotide with 14 repeats of TTAGGG (SEQ ID NO: 7); the 36B4 gene as the standard product has the nucleotide sequence of SEQ ID NO: 8. Finally, the average length of telomeres in the genomic DNA sample is calculated from the aforementioned standard curve, the telomere of the genomic DNA sample and the cycle threshold of the 36B4 gene.

Figure 107114734-A0101-12-0007-2
Figure 107114734-A0101-12-0007-2

實施例1Example 1 刺梨萃取物之製備Preparation of Prickly Pear Extract

首先,洗淨及乾燥包含果皮與刺之完整刺梨果實,使用均質機將其粗碎。其次,以水、醇類、或醇水混合物為溶劑對刺梨果實均質物進行萃取。該溶劑與該刺梨果實均質物混合之液固比為5~20:1~5。萃取溫度為介於50℃至100℃,較佳為70℃至95℃。本實施例中萃取時間為0.5至3小時。 First, wash and dry the whole prickly pear fruit including the peel and thorns, and use a homogenizer to coarsely crush it. Secondly, the homogenate of Cili fruit is extracted with water, alcohol, or alcohol-water mixture as the solvent. The liquid-solid ratio of the mixture of the solvent and the homogenate of the prickly pear fruit is 5-20:1-5. The extraction temperature is between 50°C and 100°C, preferably between 70°C and 95°C. The extraction time in this embodiment is 0.5 to 3 hours.

經上述萃取步驟所得刺梨萃取物冷卻至室溫後,可以400目(mesh)之濾網過濾,以移除殘餘固體物。該過濾後的刺梨萃取物可進一步在45℃~70℃進行減壓濃縮而獲得一濃縮產物。為獲得固態的刺梨萃取物,可將前述經減壓濃縮的刺梨萃取物以噴霧乾燥方式去除溶劑,因此獲得刺梨萃取物粉末。前述噴霧乾燥步驟前,刺梨萃取物可選擇性地與麥芽糊精依5~20:1~5之重量比(w/w)混合。 After cooling the prickly pear extract obtained through the above extraction step to room temperature, it can be filtered with a 400 mesh filter to remove residual solids. The filtered prickly pear extract can be further concentrated under reduced pressure at 45°C to 70°C to obtain a concentrated product. In order to obtain a solid prickly pear extract, the foregoing prickly pear extract concentrated under reduced pressure can be spray-dried to remove the solvent, thereby obtaining the prickly pear extract powder. Before the spray-drying step, the extract of Prickly Pear can be selectively mixed with maltodextrin in a weight ratio (w/w) of 5-20:1-5.

實施例2Example 2 刺梨萃取物減少細胞損傷及促進DNA修復與細胞回春Prickly Pear extract reduces cell damage and promotes DNA repair and cell rejuvenation

本實施例以人類基因體晶片分析人類單核細胞株THP-1經刺梨之水萃取物處理後,其基因體表現的變化。刺梨之醇萃取物或醇水萃取物亦做相同分析(資料未顯示)。首先,將THP-1細胞依1.5×105個細胞/孔接種於含有2mL RPMI細胞培養基的6孔盤的各孔,在37℃下培養24小時後,移除該細胞培養基並以PBS溶液清洗細胞。其後,將500μL之1mg/mL刺梨水萃取物與500μL不含FBS之RPMI細胞培養基添加至各孔細胞(實驗組),或者僅以500μL不含FBS之RPMI細胞培養基處理細胞以作為控制組。實驗組細胞在有或無10μg/mL脂多醣刺激的情況下於37℃培養6或24小時後用於基因表現分析,其指定基因之相對表現量係相對於控制組細胞之相同基因在同等培養時間後之表現量的倍數取log2值。 In this example, the human genome chip was used to analyze the changes in the gene expression of the human monocyte cell line THP-1 after being treated with the water extract of the prickly pear. The same analysis was performed on the alcohol extract or alcohol water extract of Prickly Pear (data not shown). First, THP-1 cells were seeded at 1.5×10 5 cells/well in each well of a 6-well plate containing 2 mL of RPMI cell culture medium. After culturing at 37°C for 24 hours, the cell culture medium was removed and washed with PBS solution cell. Afterwards, add 500 μL of 1 mg/mL prickly pear water extract and 500 μL of FBS-free RPMI cell culture medium to the cells in each well (experimental group), or only treat the cells with 500 μL of FBS-free RPMI cell culture medium as a control group . Cells in the experimental group were cultured at 37°C for 6 or 24 hours with or without stimulation of 10μg/mL lipopolysaccharide, and then used for gene expression analysis. The relative expression of the designated gene was compared with the same gene in the control group. The multiple of the expression after time is taken as the log2 value.

圖1顯示受脂多醣刺激的THP-1細胞在有或無刺梨水萃取物處理24小時後相對於控制組細胞的SOD2基因之相對表現量。依據圖1,相比單純接受脂多醣刺激的THP-1細胞,同時對細胞施予刺梨萃取物明顯提升SOD2之基因表現,此結果說明刺梨萃取物能提高細胞移除活性氧物質的能力,因此保護細胞免於氧化壓力的傷害,例如來自細胞本身及環境的自由基所造成的氧化傷害。 Figure 1 shows the relative expression level of SOD2 gene in THP-1 cells stimulated by lipopolysaccharide after 24 hours of treatment with or without the water extract of prickly pear, relative to the SOD2 gene of the control group. According to Figure 1, compared with THP-1 cells that were stimulated by lipopolysaccharide, the administration of Prickly Pear extract to the cells at the same time significantly improved the gene expression of SOD2. This result indicates that Prickly Pear extract can improve the ability of cells to remove reactive oxygen species. Therefore, it protects cells from oxidative stress, such as oxidative damage caused by free radicals from the cell itself and the environment.

圖2顯示受脂多醣刺激的THP-1細胞在有或無刺梨水萃取物處理6小時後相對於控制組細胞的CCL3基因之相對表現量。圖3顯示受脂多醣刺激的THP-1細胞在有或無刺梨水萃取物處理6小時後相對於控制組細胞的IL-1RA與IL-10基因之相對表現量。依據圖2至圖3,相比單純接受脂多醣刺激的THP-1細胞,同時對細胞施予刺梨萃取物明顯抑制與發炎反應相關的CCL3基因之表現,並且提升抗發炎細胞激素IL-1RA與IL-10之基因表現,此結果說明刺梨萃取物能抑制免疫細胞誘使發炎反應發生,因此減少個體細胞因過度發炎反應而受損。 Figure 2 shows the relative expression level of the CCL3 gene of THP-1 cells stimulated by lipopolysaccharide after 6 hours of treatment with or without the water extract of Prickly Pear, relative to the cells of the control group. Figure 3 shows the relative expression levels of IL-1RA and IL-10 genes in THP-1 cells stimulated by lipopolysaccharide after 6 hours of treatment with or without the water extract of Prickly Pear, relative to cells in the control group. According to Figures 2 to 3, compared with THP-1 cells stimulated by lipopolysaccharide alone, the administration of Prickly Pear extract to the cells at the same time significantly inhibits the expression of the CCL3 gene related to inflammation, and enhances the anti-inflammatory cytokine IL-1RA With the gene expression of IL-10, this result shows that Prickly Pear extract can inhibit immune cells to induce inflammation, thereby reducing individual cell damage due to excessive inflammation.

圖4顯示受脂多醣刺激的THP-1細胞在有或無刺梨水萃取物處理6小時後相對於控制組細胞的MPG、ERCC6、及XRCC5基因之相對表現量。依據圖4,相比單純接受脂多醣刺激的THP-1細胞,同時對細胞施予刺梨萃取物明顯增強前述三種DNA修復蛋白的基因表現,此結果說明刺梨萃取物能提升細胞對受損DNA或基因的修復能力,故可維持基因的正常運作。 Figure 4 shows the relative expression levels of MPG, ERCC6, and XRCC5 genes in THP-1 cells stimulated by lipopolysaccharide after 6 hours of treatment with or without the water extract of Prickly Pear, relative to cells in the control group. According to Figure 4, compared with THP-1 cells that were stimulated by lipopolysaccharide alone, the administration of Prickly Pear extract to the cells at the same time significantly enhanced the gene expression of the aforementioned three DNA repair proteins. This result indicates that Prickly Pear extract can enhance the damage of cells. The repair ability of DNA or genes can maintain the normal operation of genes.

圖5顯示經刺梨水萃取物處理6小時或24小時的THP-1細胞相對於控制組細胞的CCT2、CCT5、CCT6A、CCT7、及CCT8基因之相對表現量。依據圖5,刺梨萃取物之處理提升THP-1細胞之伴隨蛋白T複合體次單元之基因表現,包含CCT2、CCT5、CCT6A、CCT7、及CCT8基因。此結果說明刺梨萃取物能增加協助蛋白質摺疊之伴隨蛋白T複合體的合成,因此有益於細胞內蛋白質具有正常結構及發揮正常功能。 Figure 5 shows the relative expression levels of CCT2, CCT5, CCT6A, CCT7, and CCT8 genes in THP-1 cells treated with Cili water extract for 6 hours or 24 hours relative to control group cells. According to Fig. 5, the treatment of Prickly Pear extract enhances the gene expression of the concomitant protein T complex subunit of THP-1 cells, including CCT2, CCT5, CCT6A, CCT7, and CCT8 genes. This result indicates that Prickly Pear extract can increase the synthesis of the accompanying protein T complex that assists in protein folding, and is therefore beneficial to the normal structure and function of intracellular proteins.

圖6顯示經刺梨水萃取物處理6小時或24小時的THP-1細胞相對於控制組細胞的PARP1、PARP3、PARP4、PARP8、及PARP11基因之相對表現量。依據圖6,刺梨萃取物之處理會抑制THP-1細胞中多種聚ADP核糖聚合酶(PARP)之基因表現。鑒於先前研究指出該種酵素活性之抑制可改善粒線體活性,此結果顯示刺梨萃取物能增加粒線體活性,因而改善細胞的能量產生。基於圖1-6之實驗結果,刺梨萃取物具有使細胞回春的功效。 Figure 6 shows the relative expression levels of PARP1, PARP3, PARP4, PARP8, and PARP11 genes in THP-1 cells treated with Cili water extract for 6 hours or 24 hours relative to control group cells. According to Figure 6, the treatment of Prickly Pear extract inhibits the gene expression of multiple poly ADP ribose polymerase (PARP) in THP-1 cells. In view of previous studies that the inhibition of this enzyme activity can improve mitochondrial activity, this result shows that Cili extract can increase mitochondrial activity, thereby improving cell energy production. Based on the experimental results shown in Figures 1-6, Cili extract has the effect of rejuvenating cells.

實施例3Example 3 刺梨萃取物增強端粒酶反應相關基因之表現Prickly pear extract enhances the expression of telomerase-related genes

先前研究揭露提高細胞中的端粒酶活性可促進細胞生長。為探討刺梨萃取物對端粒酶反應相關基因表現的影響,以qPCR測定人類單核細胞株THP-1經刺梨之水萃取物處理後,其端粒酶反轉錄酶(TERT)及端粒酶RNA組分(TERC)之基因表現變化。首先,將THP-1細胞依1.5×105個細胞/孔接種於含有2mL RPMI細胞培養基的6孔盤的各孔,在37℃下培養24小時後,移除該細胞培養基並以PBS溶液清洗細胞。其後,將500μL之2mg/mL刺梨水萃取物與500μL不含FBS之RPMI細胞培養基添加至各孔細胞(實驗組),或者僅以500μL不含FBS之RPMI細胞培養基處理細胞以作為控制組。前述二組細胞於37℃培養6小時後用於qPCR分析。 Previous studies have revealed that increasing the telomerase activity in cells can promote cell growth. In order to explore the effect of Cili pear extract on the expression of genes related to telomerase reaction, qPCR was used to determine the telomerase reverse transcriptase (TERT) and terminal enzymes of human monocytic cell line THP-1 after treatment with Cili water extract. Changes in gene expression of granzyme RNA component (TERC). First, THP-1 cells were seeded at 1.5×10 5 cells/well in each well of a 6-well plate containing 2 mL of RPMI cell culture medium. After culturing at 37°C for 24 hours, the cell culture medium was removed and washed with PBS solution cell. Afterwards, 500μL of 2mg/mL prickly pear water extract and 500μL of FBS-free RPMI cell culture medium were added to the cells in each well (experimental group), or only 500μL of FBS-free RPMI cell culture medium was used to treat the cells as a control group . The aforementioned two groups of cells were cultured at 37°C for 6 hours and then used for qPCR analysis.

圖7顯示經刺梨水萃取物處理6小時之THP-1細胞與控制組細胞的TERT與TERC基因的相對表現量,圖中縱座標之相對表現量表示相對於控制組細胞中相同基因之RNA表現量的倍數。依據圖7,對THP-1細胞施予刺梨萃取物分別提高TERT與TERC基因的表現量達2倍及1.5倍。此結果說明刺梨萃取物能增加細胞中的端粒酶反應及延長端粒,因此具備延長細胞生命或延緩老化的效果。 Figure 7 shows the relative expression levels of TERT and TERC genes in THP-1 cells and control group cells treated with water extract of Cili pear for 6 hours. The relative expression level of the ordinate in the figure represents the RNA relative to the same gene in the control group cells. The multiple of the performance. According to Figure 7, the administration of Prickly Pear extract to THP-1 cells increased the expression levels of TERT and TERC genes by 2 times and 1.5 times, respectively. This result shows that Prickly Pear extract can increase the telomerase reaction in cells and lengthen telomeres, so it has the effect of prolonging cell life or delaying aging.

實施例4Example 4 刺梨萃取物抑制染色體端粒長度之縮短Prickly pear extract inhibits the shortening of chromosome telomere length 4.1對抗化學藥物所致端粒縮短4.1 Anti-chemical drug-induced telomere shortening

本實施例探討刺梨之水萃取物對人類皮膚纖維母細胞CCD-966SK之染色體端粒的保護作用。首先,CCD-966SK細胞依1.5×105個細胞/盤接種於各含有2mL MEM細胞培養基的三個35mm培養盤,在37℃下培養隔夜後,自各培養盤取半數細胞(第0天)分裝於RNA穩定液(RNAlater solution;Ambion)並儲存於-20℃以待後續使用,剩餘細胞則分別接種至另三個35mm培養盤,於37℃培養隔夜。其後,該三盤細胞中的一盤細胞以30μM化療藥物依託泊西(etoposide)處理,另一盤細胞以30μM依託泊西及0.5mg/mL刺梨水萃取物處理,餘下一盤細胞不予藥物及刺梨萃取物處理而作為控制組。經過5天培養,收集該三組細胞(第5天)。藉由核酸自動萃取系統(tacoTM automatic nucleic acid extraction system;GeneReach Biotechnology)及隨附DNA萃取套組(tacoTM DNA/RNA extraction kit)自前述第0天及第5天收集得之細胞中獲得基因體DNA,用於qPCR及端粒長度測定。如圖8所示,相對於控制組細胞,依託泊西之處理使端粒的相對長度明顯縮短,但刺梨水萃取物之處理卻能減緩此端粒縮短現象,說明刺梨萃取物能維持受化學傷害之端粒的長度。 This example explores the protective effect of the water extract of Prickly Pear on the chromosome telomeres of human skin fibroblasts CCD-966SK. First, CCD-966SK cells were seeded at 1.5×10 5 cells/plate on three 35mm culture plates each containing 2 mL of MEM cell culture medium. After culturing overnight at 37°C, half of the cells were taken from each plate (day 0). Installed in RNA stabilization solution (RNAlater solution; Ambion) and stored at -20°C for subsequent use. The remaining cells were respectively inoculated into three other 35mm culture plates and incubated at 37°C overnight. Afterwards, one plate of cells in the three plates was treated with 30μM chemotherapeutic drug etoposide (etoposide), and the other plate was treated with 30μM etoposide and 0.5mg/mL prickly pear water extract, and the remaining plate was not treated with etoposide. Treated with medicine and prickly pear extract as the control group. After 5 days of culture, the three groups of cells were collected (day 5). Genes were obtained from the cells collected on day 0 and day 5 by using the taco TM automatic nucleic acid extraction system (GeneReach Biotechnology) and the accompanying DNA extraction kit (taco TM DNA/RNA extraction kit) Body DNA, used for qPCR and telomere length determination. As shown in Figure 8, compared with the control group of cells, the treatment of Etopoxil significantly shortened the relative length of telomeres, but the treatment of the water extract of Prickly Pear can alleviate the shortening of telomeres, indicating that the extract of Prickly Pear can maintain The length of the chemically damaged telomere.

4.2對抗紫外線(UV)照射所致端粒縮短4.2 Resistance to telomere shortening caused by ultraviolet (UV) radiation

CCD-966SK細胞依1.5×105個細胞/盤接種於各含有2mL MEM細胞培養基的三個35mm培養盤,在37℃下培養隔夜後,其中二盤細胞予以1J/cm2 UVA(波長320-400nm)照射,另一盤細胞不予UVA照射而設為控制組。自各培養盤取半數細胞(第0天)分裝於RNA穩定液(RNAlater solution;Ambion)並儲存於-20℃以待後續使用,剩餘細胞則分別接種至另三個35mm培養盤,於37℃培養隔夜。其後,該二盤經UVA照射細胞中的一盤細胞以0.5mg/mL刺梨水萃取物處理,另一盤細胞不予處理。經過二次繼代培養且每次重複前述紫外線照射步驟,收集該三組細胞(第7天)。藉由核酸自動萃取系統(tacoTM automatic nucleic acid extraction system;GeneReach Biotechnology)及隨附DNA萃取套組(tacoTM DNA/RNA extraction kit)自前述第0天及第7天收集得之細胞中獲得基因體DNA,用於qPCR及端粒長度測定。圖9顯示刺梨水萃取物對紫外線照射所致皮膚細胞端粒縮短的抑制作用。如圖9所示,相對於控制組細胞,UVA照射使端粒的相對長度明顯縮短,但刺梨水萃取物之處理卻能大幅減少此端粒縮短現象,說明刺梨萃取物能維持因紫外線受損之端粒的長度,即刺梨萃取物具有抗光老化作用。 CCD-966SK cells were seeded at 1.5×10 5 cells/plate on three 35mm culture plates each containing 2mL MEM cell culture medium. After culturing overnight at 37°C, the two plates of cells were given 1J/cm 2 UVA (wavelength 320- 400nm) irradiation, another plate of cells was not irradiated with UVA and set as the control group. Take half of the cells from each culture plate (day 0) and aliquot them into RNA stabilization solution (RNAlater solution; Ambion) and store at -20°C for subsequent use. The remaining cells are respectively inoculated into three other 35mm culture plates at 37°C. Cultivate overnight. Afterwards, the cells in one of the two plates of UVA-irradiated cells were treated with 0.5 mg/mL prickly pear water extract, and the cells in the other plate were not treated. After two subcultures and repeat the aforementioned ultraviolet irradiation steps each time, the three groups of cells were collected (day 7). GeneReach Biotechnology (Taco TM automatic nucleic acid extraction system; GeneReach Biotechnology) and accompanying DNA extraction kit (taco TM DNA/RNA extraction kit) were used to obtain genes from the cells collected on day 0 and day 7. Body DNA, used for qPCR and telomere length determination. Figure 9 shows the inhibitory effect of water extract of Cili pear on the shortening of skin cell telomeres caused by ultraviolet radiation. As shown in Figure 9, compared with the control group cells, UVA irradiation significantly shortened the relative length of telomeres, but the treatment of the water extract of Cili pear can greatly reduce this phenomenon of telomere shortening, indicating that the extract of Cili pear can maintain the effect of ultraviolet rays. The length of damaged telomeres, that is, prickly pear extract has anti-photoaging effect.

綜上所述,上述實驗顯示刺梨萃取物能同時減少氧化壓力或發炎造成的細胞損傷及維持基因、蛋白質、及粒線體的正常運作,並且能增加端粒酶反應與減少端粒因化學藥物或紫外線照射而受損,最終導致細胞回春的效果。因此,本發明提供刺梨萃取物用於製備細胞回春組合物之用途,該組合物可為粉末狀、顆粒狀、液狀、膠狀或膏狀,且可製成食品、飲品、藥品、試劑或營養補充劑,藉由口服、皮膚塗抹等方式給予一個體。 In summary, the above experiments show that Cili extract can simultaneously reduce cell damage caused by oxidative stress or inflammation and maintain the normal functioning of genes, proteins, and mitochondria, and can increase telomerase reaction and reduce telomere due to chemistry. Damage caused by drugs or ultraviolet radiation will eventually lead to the rejuvenation of cells. Therefore, the present invention provides the use of Prickly Pear extract for preparing cell rejuvenation composition, which can be powder, granular, liquid, gel or paste, and can be made into food, drink, medicine, reagent Or nutritional supplements, given to a body by oral administration, skin application, etc.

<110> 大江生醫股份有限公司 <110> Dajiang Biomedical Co., Ltd.

<120> 刺梨萃取物用於製備細胞回春組合物之用途 <120> Use of Prickly Pear extract for preparing cell rejuvenation composition

<130> 106B0482-I1 <130> 106B0482-I1

<160> 12 <160> 12

<170> PatentIn version 3.5 <170> PatentIn version 3.5

<210> 1 <210> 1

<211> 19 <211> 19

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> PCR引子 <223> PCR primer

<400> 1

Figure 107114734-A0101-12-0012-3
<400> 1
Figure 107114734-A0101-12-0012-3

<210> 2 <210> 2

<211> 21 <211> 21

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> PCR引子 <223> PCR primer

<400> 2

Figure 107114734-A0101-12-0012-4
<400> 2
Figure 107114734-A0101-12-0012-4

<210> 3 <210> 3

<211> 18 <211> 18

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> PCR引子 <223> PCR primer

<400> 3

Figure 107114734-A0101-12-0013-5
<400> 3
Figure 107114734-A0101-12-0013-5

<210> 4 <210> 4

<211> 21 <211> 21

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> PCR引子 <223> PCR primer

<400> 4

Figure 107114734-A0101-12-0013-6
<400> 4
Figure 107114734-A0101-12-0013-6

<210> 5 <210> 5

<211> 20 <211> 20

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> PCR引子 <223> PCR primer

<400> 5

Figure 107114734-A0101-12-0013-7
<400> 5
Figure 107114734-A0101-12-0013-7

<210> 6 <210> 6

<211> 20 <211> 20

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> PCR引子 <223> PCR primer

<400> 6

Figure 107114734-A0101-12-0013-8
<400> 6
Figure 107114734-A0101-12-0013-8

<210> 7 <210> 7

<211> 84 <211> 84

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> 端粒標準品 <223> Telomere Standard

<400> 7

Figure 107114734-A0101-12-0014-9
<400> 7
Figure 107114734-A0101-12-0014-9

<210> 8 <210> 8

<211> 75 <211> 75

<212> DNA <212> DNA

<213> Homo sapiens <213> Homo sapiens

<400> 8

Figure 107114734-A0101-12-0014-10
<400> 8
Figure 107114734-A0101-12-0014-10

<210> 9 <210> 9

<211> 39 <211> 39

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> PCR引子 <223> PCR primer

<400> 9

Figure 107114734-A0101-12-0014-11
<400> 9
Figure 107114734-A0101-12-0014-11

<210> 10 <210> 10

<211> 39 <211> 39

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> PCR引子 <223> PCR primer

<400> 10

Figure 107114734-A0101-12-0015-12
<400> 10
Figure 107114734-A0101-12-0015-12

<210> 11 <210> 11

<211> 23 <211> 23

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> PCR引子 <223> PCR primer

<400> 11

Figure 107114734-A0101-12-0015-13
<400> 11
Figure 107114734-A0101-12-0015-13

<210> 12 <210> 12

<211> 25 <211> 25

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> PCR引子 <223> PCR primer

<400> 12

Figure 107114734-A0101-12-0015-14
<400> 12
Figure 107114734-A0101-12-0015-14

Claims (8)

一種刺梨萃取物之用途,係用於製備促進細胞內受損基因修復及蛋白質正常摺疊之醫藥組合物,其中該刺梨萃取物係以一溶劑萃取一刺梨而獲得。 A use of Prickly Pear extract is to prepare a pharmaceutical composition that promotes damaged gene repair in cells and normal protein folding, wherein the Prickly Pear extract is obtained by extracting a Prickly Pear with a solvent. 如申請專利範圍第1項所述之用途,其中該溶劑為水、醇類、或醇水混合物。 The use described in item 1 of the scope of the patent application, wherein the solvent is water, alcohol, or a mixture of alcohol and water. 如申請專利範圍第1項所述之用途,其中該刺梨萃取物增強一DNA修復蛋白之基因表現,該DNA修復蛋白係選自於由MPG、ERCC6、XRCC5、及其任意組合所組成的群組。 The use described in item 1 of the scope of patent application, wherein the prickly pear extract enhances the gene expression of a DNA repair protein selected from the group consisting of MPG, ERCC6, XRCC5, and any combination thereof group. 如申請專利範圍第1項所述之用途,其中該刺梨萃取物促進一伴隨蛋白T複合體之合成。 The use as described in item 1 of the scope of patent application, wherein the prickly pear extract promotes the synthesis of a concomitant protein T complex. 如申請專利範圍第4項所述之用途,其中該刺梨萃取物增強該伴隨蛋白T複合體(CCT)之一蛋白次單元之基因表現,該蛋白次單元係選自於由CCT2、CCT5、CCT6A、CCT7、CCT8、及其任意組合所組成的群組。 The use as described in item 4 of the scope of patent application, wherein the prickly pear extract enhances the gene expression of a protein subunit of the companion protein T complex (CCT), and the protein subunit is selected from CCT2, CCT5, A group consisting of CCT6A, CCT7, CCT8, and any combination thereof. 如申請專利範圍第1項所述之用途,其中該溶劑與該刺梨之液固比為5~20:1~5。 The use as described in item 1 of the scope of patent application, wherein the liquid-solid ratio of the solvent to the prickly pear is 5-20:1-5. 如申請專利範圍第1項所述之用途,其中該萃取係在50℃~100℃進行。 For the purposes described in item 1 of the scope of patent application, the extraction is carried out at 50°C to 100°C. 如申請專利範圍第1項所述之用途,其中該刺梨萃取物係為一刺梨之水萃取物,其濃度為至少0.5mg/mL。 The use described in item 1 of the scope of the patent application, wherein the prickly pear extract is a water extract of prickly pear, the concentration of which is at least 0.5 mg/mL.
TW107114734A 2017-11-28 2018-04-30 Use of rosa roxburghii fruit extracts for manufacture of composition for cell rejuvenation TWI719303B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201810741808.3A CN109833358A (en) 2017-11-28 2018-07-05 Rosa roxburghii Tratt extract is used to prepare the purposes of cell return of spring composition
US16/100,956 US20190160131A1 (en) 2017-11-28 2018-08-10 Method for cell rejuvenation using rosa roxburghii fruit extracts

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762591604P 2017-11-28 2017-11-28
US62/591,604 2017-11-28

Publications (2)

Publication Number Publication Date
TW201924706A TW201924706A (en) 2019-07-01
TWI719303B true TWI719303B (en) 2021-02-21

Family

ID=68048729

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107114734A TWI719303B (en) 2017-11-28 2018-04-30 Use of rosa roxburghii fruit extracts for manufacture of composition for cell rejuvenation

Country Status (1)

Country Link
TW (1) TWI719303B (en)

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Ma YX et al., "The aging retarding effect of Long-Life CiLi'" Mechanisms of Ageing and Development, vol.96, no.1-3, p.171-180, 1997/06
Martínez P et al., "Telomere-driven diseases and telomere-targeting therapies" Journal of Cell Biology, vol.216, no.4, p.875-887, 2017/03/02
Xu P et al., "Flavonoids of Rosa roxburghii Tratt act as radioprotectors" Asian Pacific Journal of Cancer Prevention, vol.15,no.19, p.8171-8175, 2014/01/01
Xu P et al., "Flavonoids of Rosa roxburghii Tratt Exhibit Anti‐Apoptosis Properties by Regulating PARP‐1/AIF", Journal of Cellular Biochemistry, vol.118, no.11, p.3943-3952, 2017/04/11
Xu P et al., "Flavonoids of Rosa roxburghii Tratt Exhibit Anti‐Apoptosis Properties by Regulating PARP‐1/AIF", Journal of Cellular Biochemistry, vol.118, no.11, p.3943-3952, 2017/04/11 Ma YX et al., "The aging retarding effect of Long-Life CiLi'" Mechanis *
Xu P et al., "Flavonoids of Rosa roxburghii Tratt exhibit radioprotection and anti-apoptosis properties via the Bcl-2 (Ca2+)/Caspase-3/PARP-1 pathway" Apoptosis, vol.21, no.10, p.1125-1143, 2016/07/11

Also Published As

Publication number Publication date
TW201924706A (en) 2019-07-01

Similar Documents

Publication Publication Date Title
Rodríguez‐Nogales et al. Differential intestinal anti‐inflammatory effects of Lactobacillus fermentum and Lactobacillus salivarius in DSS mouse colitis: impact on microRNAs expression and microbiota composition
Wang et al. In vitro immunomodulatory effects of acidic exopolysaccharide produced by Lactobacillus planetarium JLAU103 on RAW264. 7 macrophages
JP7128117B2 (en) High Rebaudioside C Containing Stevia Plant
TWI702055B (en) Pachyrhizus erosus fermented extracts and the use thereof for enhancing the gene expression of col, timp, lox, eln, has, sod, tcp1 and ung, and for reducing the skin melanin content
US20190160131A1 (en) Method for cell rejuvenation using rosa roxburghii fruit extracts
Guruprasad et al. Influence of Amalaki Rasayana on telomerase activity and telomere length in human blood mononuclear cells
TWI719303B (en) Use of rosa roxburghii fruit extracts for manufacture of composition for cell rejuvenation
Han et al. Transcriptomic landscape of Dendrobium huoshanense and its genes related to polysaccharide biosynthesis
CN110734869B (en) Probiotic strain for delaying aging, composition and application thereof
Wang et al. Investigation of the Potential Mechanism Governing the Effect of the Shen Zhu San on COVID‐19 by Network Pharmacology
Du et al. Co-expression network analysis identifies innate immune signatures for Albizia julibrissin saponin active fraction-adjuvanted avian influenza vaccine
Kim et al. Comparison of global transcriptional responses to primary and secondary Eimeria acervulina infections in chickens
CN109402123A (en) A kind of circular rna hsa-circ-0073004 and its specificity amplification primer and application
KR20100032713A (en) Extract of sparassis crispa and its use as anti-inflammatory medicine
Tang et al. Identification and characterization of immune-related microRNAs in hybrid snakehead (Channa maculata♀× Channa argus♂) after treated by Echinacea purpurea (Linn.) Moench
Redmond Jr et al. Spatiotemporal patterns of gene expression during fetal monkey brain development
Anyona et al. Ingestion of hemozoin by peripheral blood mononuclear cells alters temporal gene expression of ubiquitination processes
CN110710682A (en) Application of tartary buckwheat seed coat extract in improving mitochondrial activity, promoting anti-aging gene expression and inhibiting protein glycosylation
TWI777518B (en) Use of tartary buckwheat husk extracts for retarding aging of skin
RU2431149C2 (en) Method for assessment of renal survival rate in patients with chronic glomerulonephritis by interleukin gene polymorphism values
Hoffmann et al. Gene expression levels in small specimens from patients detected using oligonucleotide arrays
TWI736855B (en) Use of passiflora flower extracts for enhancing mitochondrial activity and anti-aging gene expression in skin cells
Zhou et al. The molecular basis for host responses to Marek's disease viruses integrated with different retro-viral long terminal repeat
JP7349153B2 (en) Immunologically active substances and crude products and compositions containing them
Kim et al. Gene expression profiling in mouse liver infected with Clonorchis sinensis metacercariae